Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)-a systematic review protocol.
- DOI
- 10.1186/s13643-022-01997-2
- Published
- 2022 Jul 1
- Container
- Systematic reviews
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13643-022-01997-2,
title = {Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)-a systematic review protocol.},
author = {Lehnert T and Röver C and Köpke S and Rio J and Chard D and Fittipaldo AV and Friede T and Heesen C and Rahn AC},
year = {2022},
journal = {Systematic reviews},
doi = {10.1186/s13643-022-01997-2},
url = {https://doi.org/10.1186/s13643-022-01997-2}
}RIS
TY - JOUR TI - Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)-a systematic review protocol. AU - Lehnert T AU - Röver C AU - Köpke S AU - Rio J AU - Chard D AU - Fittipaldo AV AU - Friede T AU - Heesen C AU - Rahn AC PY - 2022 JO - Systematic reviews DO - 10.1186/s13643-022-01997-2 UR - https://doi.org/10.1186/s13643-022-01997-2 ER -
APA
T, L., C, R., S, K., J, R., D, C., AV, F., T, F., C, H., & AC, R. (2022). Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)-a systematic review protocol.. Systematic reviews. https://doi.org/10.1186/s13643-022-01997-2
Source records
- pubmed · retrieved 2026-09-26T08:03:31.342Z